Reply to the letters to the editor 'Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma' by Diwakar et al.
暂无分享,去创建一个
D. Schadendorf | B. Schilling | W. Sondermann | E. Livingstone | L. Zimmer | U. Hillen | K. Griewank | U. Hillen | Bastian Schilling | D. Schadendorf